00:52:17 EDT Mon 06 May 2024
Enter Symbol
or Name
USA
CA



Q:CPIX - CUMBERLAND PHARMACEUTICALS INC - http://www.cumberlandpharma.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
CPIX - Q0.11.33·1.692.01.58+0.010.69.713581.59  1.6499  1.5752.3587  1.4216:00:08Apr 3015 min RT 2¢

Recent Trades - Last 10 of 58
Time ETExPriceChangeVolume
16:00:08Q1.580.0713
16:00:01Q1.580.01226
16:00:01Q1.580.071
16:00:01Q1.580.071
16:00:01Q1.580.071
16:00:01Q1.580.071
15:59:34Q1.610.102
15:59:32Q1.610.1029
15:59:32Q1.610.103
15:59:32Q1.610.101

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-04-30 16:05U:CPIXNews ReleaseCUMBERLAND PHARMACEUTICALS TO ANNOUNCE FIRST QUARTER 2024 FINANCIAL RESULTS
2024-04-02 16:05U:CPIXNews ReleaseNEW REPORT SUPPORTS USE OF CALDOLOR(TM) AS A STANDARD OF CARE ACROSS PATIENT POPULATIONS
2024-03-05 16:05U:CPIXNews ReleaseCumberland Pharmaceuticals Reports Annual 2023 Financial Results
2024-02-27 16:05U:CPIXNews ReleaseCUMBERLAND PHARMACEUTICALS TO ANNOUNCE ANNUAL 2023 FINANCIAL RESULTS
2023-11-07 16:05U:CPIXNews ReleaseCumberland Pharmaceuticals Reports Third Quarter 2023 Financial Results
2023-10-31 16:05U:CPIXNews ReleaseCUMBERLAND PHARMACEUTICALS TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTS
2023-10-10 16:05U:CPIXNews ReleaseNEW VIBATV ‚ ® PEDIATRIC PUBLICATION HIGHLIGHTS ITS SAFETY IN PATIENTS 2 TO 17 YEARS OF AGE
2023-08-08 16:05U:CPIXNews ReleaseCumberland Pharmaceuticals Reports Revenue and Earnings Growth Second Quarter 2023
2023-08-01 16:05U:CPIXNews ReleaseCUMBERLAND PHARMACEUTICALS TO ANNOUNCE SECOND QUARTER 2023 FINANCIAL RESULTS
2023-06-26 09:00U:CPIXNews ReleaseNEW PUBLICATION SUPPORTS THE USE OF CALDOLOR ‚ ® IN NEWBORN PEDIATRIC PATIENTS
2023-05-23 09:00U:CPIXNews ReleaseCUMBERLAND PHARMACEUTICALS ANNOUNCES FDA CLEARANCE OF IND FOR NEW TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS
2023-05-15 09:00U:CPIXNews ReleaseCALDOLOR ‚ ® NOW FDA APPROVED FOR TREATMENT OF FEVER & PAIN IN INFANTS
2023-05-09 16:05U:CPIXNews ReleaseCumberland Pharmaceuticals Reports First Quarter 2023 Financial Results & Company Update